These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
50 related articles for article (PubMed ID: 20602608)
1. Endocannabinoid system, pharmacogenomics and response to therapy. Onaivi ES Pharmacogenomics; 2010 Jul; 11(7):907-10. PubMed ID: 20602608 [No Abstract] [Full Text] [Related]
2. The endocannabinoid system: a general view and latest additions. De Petrocellis L; Cascio MG; Di Marzo V Br J Pharmacol; 2004 Mar; 141(5):765-74. PubMed ID: 14744801 [TBL] [Abstract][Full Text] [Related]
3. Update on the endocannabinoid system as an anticancer target. Malfitano AM; Ciaglia E; Gangemi G; Gazzerro P; Laezza C; Bifulco M Expert Opin Ther Targets; 2011 Mar; 15(3):297-308. PubMed ID: 21244344 [TBL] [Abstract][Full Text] [Related]
4. Cannabinoid receptors as therapeutic targets. Mackie K Annu Rev Pharmacol Toxicol; 2006; 46():101-22. PubMed ID: 16402900 [TBL] [Abstract][Full Text] [Related]
5. The endocannabinoid system and its relevance for nutrition. Maccarrone M; Gasperi V; Catani MV; Diep TA; Dainese E; Hansen HS; Avigliano L Annu Rev Nutr; 2010 Aug; 30():423-40. PubMed ID: 20645854 [TBL] [Abstract][Full Text] [Related]
6. The endocannabinoid system in the brain: from biology to therapy. Maccarrone M Curr Drug Targets CNS Neurol Disord; 2005 Dec; 4(6):613. PubMed ID: 16375678 [No Abstract] [Full Text] [Related]
7. [Functional role of the endocannabinoid system in emotional homeostasis]. Marco EM; Viveros MP Rev Neurol; 2009 Jan 1-15; 48(1):20-6. PubMed ID: 19145562 [TBL] [Abstract][Full Text] [Related]
8. The therapeutic potential of the endocannabinoid system for Alzheimer's disease. Karl T; Cheng D; Garner B; Arnold JC Expert Opin Ther Targets; 2012 Apr; 16(4):407-20. PubMed ID: 22448595 [TBL] [Abstract][Full Text] [Related]
10. Endocannabinoid overactivity and intestinal inflammation. Di Marzo V; Izzo AA Gut; 2006 Oct; 55(10):1373-6. PubMed ID: 16966693 [TBL] [Abstract][Full Text] [Related]
11. Endocannabinoids as mediators in the heart: a potential target for therapy of remodelling after myocardial infarction? Hiley CR; Ford WR Br J Pharmacol; 2003 Apr; 138(7):1183-4. PubMed ID: 12711614 [TBL] [Abstract][Full Text] [Related]
12. The endocannabinoid system: a modulator of brain-behavioral processes. Deadwyler SA Psychopharmacology (Berl); 2008 Jul; 198(4):447-8. PubMed ID: 18461310 [No Abstract] [Full Text] [Related]
13. The endocannabinoid system and its role in energy homeostasis and abdominal obesity management. Proceedings of a meeting, Quebec City, Canada, 20 November 2004. Int J Obes (Lond); 2006 Apr; 30 Suppl 1():S1-52. PubMed ID: 16570098 [No Abstract] [Full Text] [Related]
14. Oleamide: a member of the endocannabinoid family? Fowler CJ Br J Pharmacol; 2004 Jan; 141(2):195-6. PubMed ID: 14691053 [TBL] [Abstract][Full Text] [Related]
15. Tuning the endocannabinoid system: allosteric modulators of the CB1 receptor. Ross RA Br J Pharmacol; 2007 Nov; 152(5):565-6. PubMed ID: 17592508 [TBL] [Abstract][Full Text] [Related]
18. Sex and drug abuse: a role for retrograde endocannabinoids? Maccarrone M Trends Pharmacol Sci; 2004 Sep; 25(9):455-6. PubMed ID: 15559246 [No Abstract] [Full Text] [Related]
19. Genetic Polymorphism as a Possible Cause of Severe Postoperative Pain. Govers B; Matic M; van Schaik RHN; Klimek M J Clin Pharmacol; 2024 Mar; 64(3):378-381. PubMed ID: 37816218 [No Abstract] [Full Text] [Related]
20. Psychiatric Disorders and Cannabinoid Receptors. Joshi N; Onaivi ES Adv Exp Med Biol; 2021; 1264():131-153. PubMed ID: 33332008 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]